The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
出版年份 2017 全文链接
标题
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 1, Pages 378-386
出版商
Wiley
发表日期
2017-03-07
DOI
10.1002/jcp.25896
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The 2016 World Health Organization Classification of tumours of the Central Nervous System: what the paediatric neuroradiologist needs to know
- (2016) Sahil Chhabda et al. QUANTITATIVE IMAGING IN MEDICINE AND SURGERY
- Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials?
- (2015) Alba Fiorentino et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A microarray-based DNA methylation study of glioblastoma multiforme
- (2014) Ramon Martinez et al. Epigenetics
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome
- (2013) Shadi Lalezari et al. NEURO-ONCOLOGY
- O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w
- (2012) Emmanuèle Lechapt-Zalcman et al. CANCER
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009
- (2012) T. A. Dolecek et al. NEURO-ONCOLOGY
- Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
- (2011) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
- (2011) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
- (2011) A. L. Rivera et al. NEURO-ONCOLOGY
- Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
- (2011) Stephanie E Combs et al. Radiation Oncology
- Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference
- (2010) Luca Morandi et al. BMC CANCER
- O 6-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma
- (2010) Yukihiko Sonoda et al. International Journal of Clinical Oncology
- Addition of Bevacizumab to Standard Radiation Therapy and Daily Temozolomide Is Associated With Minimal Toxicity in Newly Diagnosed Glioblastoma Multiforme
- (2010) James J. Vredenburgh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide
- (2010) Giuseppe Minniti et al. JOURNAL OF NEURO-ONCOLOGY
- Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
- (2010) George C. Bobustuc et al. NEURO-ONCOLOGY
- Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
- (2009) J Dunn et al. BRITISH JOURNAL OF CANCER
- Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation
- (2009) Philippe Metellus et al. CANCER
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide
- (2009) Martin Glas et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma
- (2009) Jennifer L. Clarke et al. JOURNAL OF CLINICAL ONCOLOGY
- MGMTPromoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status
- (2009) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods
- (2009) Lucie Karayan-Tapon et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
- (2009) E. R. Gerstner et al. NEUROLOGY
- Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin
- (2009) Chul-Kee Park et al. NEUROPATHOLOGY
- THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS
- (2009) Van Thang Cao et al. NEUROSURGERY
- A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
- (2008) M. Schaich et al. ANNALS OF ONCOLOGY
- Common Polymorphisms in theMDM2andTP53Genes and the Relationship betweenTP53Mutations and Patient Outcomes in Glioblastomas
- (2008) Izabela Zawlik et al. BRAIN PATHOLOGY
- Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
- (2008) Angelique E. Sijben et al. JOURNAL OF NEURO-ONCOLOGY
- Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
- (2008) Izabela Zawlik et al. NEUROEPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now